Monday, Apr 13, 1998
South San Francisco, Calif. -- April 13, 1998 --Genentech, Inc. (NYSE: GNE) today announced the appointment of Walter Moore, 46, as head of the company's Government Affairs office, which is headquartered in Washington, D.C. Moore joined Genentech in September of 1993 as Sr. Director of Government Affairs. In his new position, Moore replaces David W. Beier, who recently announced his acceptance of the position of Chief Domestic Policy Advisor for Vice President Al Gore.
"The appointment of David Beier to his new Administration post speaks to the caliber and expertise of Genentech's Government Affairs staff," says Arthur D. Levinson, Ph.D., president and CEO of Genentech, Inc. "We are delighted to have Walter Moore assume this responsibility because he possesses the high level of skill, integrity, personal reputation, and demonstrated performance to effectively carry forward our Government Affairs interests."
Prior to joining Genentech, Moore served as Manager of Government Relations for Eli Lilly and Company, and prior to that as Director, Congressional Relations for Pfizer, Inc. Moore came to Washington as a staff member to Senator Lloyd Bentsen of Texas and later served as Political Director for the American Hospital Association. Moore is a graduate of Princeton University, and holds his MPA from the Lyndon B. Johnson School of Public Affairs at the University of Texas at Austin.
"Genentech's Government Affairs commitment matches our corporate mission of serving patients through the discovery, development and delivery of breakthrough medicines for persons with serious unmet medical needs. Our continued commitment to a firmly bipartisan approach to public policy issues will enable us to continue to partner with government officials at federal, state and local levels," said Dr. Levinson.
Genentech, Inc. is a leading biotechnology company that discovers, develops, manufactures and markets human pharmaceuticals for significant unmet medical needs. Eleven of the currently marketed biotechnology products stem from Genentech science, seven of which Genentech markets directly in the United States. The company has headquarters in South San Francisco, California and is traded on the New York Stock Exchange and Pacific Stock Exchange under the symbol GNE.
# # #